Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON36679Active, not recruiting
Open-label trial of esketamine (2 arms), sponsored by University of Amsterdam. Primary endpoints: fMRI BOLD activation patterns, Functional connectivity and 4 more. Started May 2012; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON36679.